Back to Search
KENNETH MAYER, M.D.
M.D.
Infectious Disease Physician
NPI: 1861439812Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
44919(MA)MD06212(RI)
Clinical Trials (4)
4
Linked Trials
0
Recruiting
2
With Results
HIV Non Occupational Post-Exposure Prophylaxis (PEP)
NCT00594646COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
HIV Non-Occupational Post-Exposure Prophylaxis
NCT01855867COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Biktarvy for Non-Occupational Post-Exposure Prophylaxis (nPEP)
NCT03499483COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Pre-exposure Prophylaxis Adherence Intervention for MSM
NCT01632397COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Safety and Tolerability of Once Daily Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Exposure.
PMID 34991141·J Acquir Immune Defic Syndr·2022
8-other
Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherence.
PMID 22267017·J Acquir Immune Defic Syndr·2012
3-trial
Sexual and gender minority health: what we know and what needs to be done.
PMID 18445789·Am J Public Health·2008
8-other
Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings.
PMID 18033828·J Med Microbiol·2007
8-other
Supporting clinical research: a unique catalyst--the remarkable legacy of Dr. Mathilde Krim.
PMID 16839245·AIDS Patient Care STDS·2006
8-other
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.
PMID 16470118·AIDS·2006
3-trial
HIV care providers and prevention: opportunities and challenges.
PMID 15385911·J Acquir Immune Defic Syndr·2004
8-other
Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy.
PMID 12902807·J Acquir Immune Defic Syndr·2003
4-observational
Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women.
PMID 12556685·AIDS·2003
3-trial
A label-free immunoassay based upon localized surface plasmon resonance of gold nanorods.
PMID 19206599·ACS Nano·2008
8-other
Intestine-specific expression of green fluorescent protein-tagged cathepsin B: proof-of-principle experiments.
PMID 18979632·Biol Chem·2008
7-preclinical
Exploring the diversity of marine-derived fungal polyketide synthases.
PMID 17496979·Can J Microbiol·2007
8-other
Process-based reactive transport modeling of a permeable reactive barrier for the treatment of mine drainage.
PMID 16554107·J Contam Hydrol·2006
8-other
Fundamentals of surgical research course: research presentations.
PMID 16243041·J Surg Res·2005
8-other
FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.
PMID 15205237·Br J Ophthalmol·2004
7-preclinical
Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis.
PMID 15121792·J Med Genet·2004
7-preclinical
Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study.
PMID 12928902·Graefes Arch Clin Exp Ophthalmol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 164 SUMMIT AVE, FAIN BLDG., SUITE B
PROVIDENCE, RI 02906 - Phone
- (401) 793-2928
Quick Facts
- NPI
- 1861439812
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile